<生产厂家价格>

Fmoc-L-缬氨酸

Fmoc-L-缬氨酸用途

Fmoc-L-Val-OH是缬氨酸衍生物[1]。

Fmoc-L-缬氨酸名称

[ CAS 号 ]:
68858-20-8

[ 中文名 ]:
Fmoc-L-缬氨酸

[ 英文名 ]:
Fmoc-Val-OH

[中文别名 ]:

[英文别名 ]:

L-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valine
N-Fmoc-Val-OH (N-Fmoc-L-valine)
FMco-Val-OH
N-FMOC-L-VAL
FMOC-L-VAL-OH
FMOC-VAL
FMOC-VAL-OH
MFCD00037124
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-valine

Fmoc-L-缬氨酸生物活性

[ 描述 ]:

Fmoc-L-Val-OH是缬氨酸衍生物[1]。

[ 相关类别 ]:

研究领域 >> 其他

信号通路 >> 其他 >> 其他

[体外研究]

氨基酸和氨基酸衍生物已被商业化用作能量补充剂。它们影响合成代谢激素的分泌、运动期间的燃料供应、压力相关任务期间的精神表现,并防止运动引起的肌肉损伤。它们被认为是有益的能生膳食物质[1]。

[参考文献]

[1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

Fmoc-L-缬氨酸物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
551.8±33.0 °C at 760 mmHg

[ 熔点 ]:
143-147ºC

[ 分子式 ]:
C₂₀H₂₁NO₄

[ 分子量 ]:
339.385

[ 闪点 ]:
287.5±25.4 °C

[ 精确质量 ]:
339.147064

[ PSA ]:
79.12000

[ LogP ]:
4.42

[ 外观性状 ]:
白色至灰白色结晶粉末

[ 蒸汽压 ]:
0.0±1.6 mmHg at 25°C

[ 折射率 ]:
1.590

[ 储存条件 ]:
2~8°C

Fmoc-L-缬氨酸MSDS

Fmoc-L-缬氨酸安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xi:Irritant

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S22-S26-S36/37/39

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2924299090

Fmoc-L-缬氨酸合成路线

Fmoc-L-缬氨酸上下游产品

Fmoc-L-缬氨酸上游产品

Fmoc-L-缬氨酸下游产品

Fmoc-L-缬氨酸海关

[ 海关编码 ]: 2924299090

[ 中文概述 ]:
2924299090. 其他环酰胺（包括环氨基甲酸酯）（包括其衍生物以及他们的盐）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 包装

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Fmoc-L-缬氨酸文献

Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.

Cancer Sci. 106 , 747-56, (2015)

L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherap...

Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer.

Mol. Pharm. 11(10) , 3352-60, (2014)

Drug resistance becomes a formidable challenge against effective cancer therapy. Defective apoptosis in cancer cells is a key factor responsible for chemoresistance or radioresistance. Promoting apopt...

Design and synthesis of newN-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents

Eur. J. Med. Chem. 44 , 1933-40, (2009)

Twenty-four new dipeptide analogs ( 1– 24) of aurantiamide acetate were designed, synthesized, and assayed for effects on superoxide anion generation and elastase release by human neutrophils in respo...

更多文献